[CLINICAL EXPERIMENTATION OF A NEW ANTICOAGULANT DERIVATIVE OF DICOUMAROL: 3,3' METHYL-THIOPROPYLIDENE-BIN (4-HYDROXYCOUMARIN)].
D015110:4-Hydroxycoumarins; D000925:Anticoagulants; D001162:Arteriosclerosis Obliterans; D001281:Atrial Fibrillation; D035843:Biomedical Research; D003327:Coronary Disease; D001728:Dicumarol; D006973:Hypertension; D006976:Hypertension, Pulmonary; D013924:Thrombophlebitis; D014116:Toxicology
D015110:4-Hydroxycoumarins; D000925:Anticoagulants; D001728:Dicumarol; C068805:4-hydroxycoumarin
ANTICOAGULANTS; ARTERIOSCLEROSIS OBLITERANS; AURICULAR FIBRILLATION; CLINICAL RESEARCH; CORONARY DISEASE; HYPERTENSION, PULMONARY; THROMBOPHLEBITIS; TOXICOLOGIC REPORT
EXP'ERIMENTATION CLINIQUE D'UN NOUVEL ANTICOAGULANT D'ERIV'E DU DICOUMAROL: LE 3,3' M'ETHYL-THIOPROPYLID'ENE-BIS (4-HYDROXYCOUMARINE)